Prognostic Significance of Lymphocyte Percentage and IL-6 Level in Patients Undergoing Radiotherapy for Advanced Lung Cancer

This publication has 36 references indexed in Scilit:

• Prognosis value of IL-6, IL-8, and IL-1β in serum of patients with lung cancer: A fresh look at interleukins as a biomarker
  Heliyon, 2022
• IL‐6 and IL‐8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor
  Molecular Carcinogenesis, 2021
• Abandoning the Notion of Non-Small Cell Lung Cancer
  Trends in Molecular Medicine, 2019
• The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
• Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis
  Clinica Chimica Acta, 2018
• Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies
  Cancer Treatment Reviews, 2017
• Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis
  Cancer Treatment Reviews, 2015
• New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
  European Journal of Cancer, 2009
• Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
  Journal of Surgical Oncology, 2005
• Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group
  Cancer, 1984